Frost & Sullivan

AUGUST 28, 2024

BiBo Pharma is breaking capacity barriers and reducing antibody drug production costs from the international average of hundreds of dollars to just $10 per gram, offering disruptive solutions to global biopharmaceutical companies. times compared to the current 15,000L (total volume) standard in large-scale biopharmaceutical production.

Biopharmaceuticals 52

Biopharmaceuticals Construction Engineering Insurance 52

Peter Simoons

JANUARY 14, 2024

The future of business is in collaboration. Head of Alliances, Global Biopharmaceutical Company What Have I Been Reading: “ Partnering: Forge the Deep Connections That Make Great Things Happen ”* by Jean Oelwang Why Is It Relevant? In doing so, it enables the type of growth that can’t be grown by one company working alone.

Biopharmaceuticals 130

Biopharmaceuticals Alliance management Strategic alliances Construction 130

Frost & Sullivan

MAY 12, 2021

Technology, industry collaborations and a desire to innovate will help participants sustain their growth momentum and achieve manufacturing scale, finds Frost & Sullivan. May 12, 2021 – The biopharmaceutical industry is facing its biggest test in recent times. SANTA CLARA, Calif. – About Frost & Sullivan.

Biopharmaceuticals 52

Biopharmaceuticals Life science Construction Government 52

Jake Jorgovan

NOVEMBER 27, 2023

Biopharmaceutical Consulting: Supporting every aspect of the biopharma value chain, including R&D, operations, manufacturing, commercialization, and mergers and acquisitions (M&A). Their services are utilized across multiple industries including construction, banking, retail, education, and healthcare.

Life science 130

Life science Biopharmaceuticals Biotech Mergers and acquisition activities 130

Jake Jorgovan

NOVEMBER 15, 2023

As a result, Network Scientific Recruitment collaborates with a wide range of companies, from start-ups to global pharmaceutical organizations. Plus, PharmaLogics has a renowned commitment to working collaboratively with internal human resources teams for recruiting top talent. Plus, their team is really friendly.

Biopharma 130

Biopharma Life science Biotechnology Biotech 130

Frost & Sullivan

APRIL 3, 2024

Fuelling Growth: Strategic Investments, Acquisitions, and Expansions Samsung Biologics unveiled plans to expand capacity and geographic reach by initiating the construction of Bio Campus II with a $6 billion investment scheduled to begin operations in 2025 while completing its CGMP antibody-drug conjugate manufacturing facility within 2024.

Biopharmaceuticals 59

Biopharmaceuticals Biopharma Biotechnology Life science 59